Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation.

@article{Anderson2006CosteffectivenessOP,
  title={Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation.},
  author={Kristin Anderson and Judith S. Jacobson and Daniel F. Heitjan and Joshua S. Graff Zivin and Dawn Hershman and Alfred I. Neugut and Victor R. Grann},
  journal={Annals of internal medicine},
  year={2006},
  volume={144 6},
  pages={397-406}
}
BACKGROUND For BRCA1 or BRCA2 mutation carriers, decision analysis indicates that prophylactic surgery or chemoprevention leads to better survival than surveillance alone. OBJECTIVE To evaluate the cost-effectiveness of the preventive strategies that are available to unaffected women carrying a single BRCA1 or BRCA2 mutation with high cancer penetrance… CONTINUE READING